136 related articles for article (PubMed ID: 20628001)
1. Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression.
Kim YJ; Lee JS; Hong KS; Chung JW; Kim JH; Hahm KB
Cancer Prev Res (Phila); 2010 Aug; 3(8):963-74. PubMed ID: 20628001
[TBL] [Abstract][Full Text] [Related]
2. Prevention of colitis-associated carcinogenesis with infliximab.
Kim YJ; Hong KS; Chung JW; Kim JH; Hahm KB
Cancer Prev Res (Phila); 2010 Oct; 3(10):1314-33. PubMed ID: 20736334
[TBL] [Abstract][Full Text] [Related]
3. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A/J mice.
Lee SJ; Lim KT
J Biomed Sci; 2008 Jan; 15(1):111-21. PubMed ID: 17657586
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.
Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1262-7. PubMed ID: 14652292
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Abe Y; Morita E; Murano N; Yasumoto S; Toshina K; Nishikawa T; Maemura K; Hirata I; Katsu K
J Gastroenterol Hepatol; 2007 Sep; 22(9):1474-81. PubMed ID: 17716351
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T
Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
[TBL] [Abstract][Full Text] [Related]
10. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
[TBL] [Abstract][Full Text] [Related]
12. Effects of nimesulide, a cyclooxygenase-2 selective inhibitor, on colitis induced tumors.
Inoue T; Hirata I; Murano M
Inflammopharmacology; 2008 Feb; 16(1):36-9. PubMed ID: 18256803
[TBL] [Abstract][Full Text] [Related]
13. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis.
Belizon A; Balik E; Kirman I; Remotti H; Ciau N; Jain S; Whelan RL
Dis Colon Rectum; 2007 Sep; 50(9):1377-83. PubMed ID: 17668267
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
Koelink PJ; Robanus-Maandag EC; Devilee P; Hommes DW; Lamers CB; Verspaget HW
Carcinogenesis; 2009 Jul; 30(7):1217-24. PubMed ID: 19420017
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice.
Villegas I; Sánchez-Fidalgo S; de la Lastra CA
Mol Nutr Food Res; 2011 Feb; 55(2):259-67. PubMed ID: 20848615
[TBL] [Abstract][Full Text] [Related]
17. Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
Loddenkemper C; Keller S; Hanski ML; Cao M; Jahreis G; Stein H; Zeitz M; Hanski C
Int J Cancer; 2006 Jun; 118(11):2750-7. PubMed ID: 16385573
[TBL] [Abstract][Full Text] [Related]
18. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
Fichera A; Little N; Dougherty U; Mustafi R; Cerda S; Li YC; Delgado J; Arora A; Campbell LK; Joseph L; Hart J; Noffsinger A; Bissonnette M
J Surg Res; 2007 Oct; 142(2):239-45. PubMed ID: 17574271
[TBL] [Abstract][Full Text] [Related]
19. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions.
Clapper ML; Cooper HS; Chang WC
Acta Pharmacol Sin; 2007 Sep; 28(9):1450-9. PubMed ID: 17723178
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
